Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000932732 | SCV001078419 | likely benign | not provided | 2024-10-02 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000932732 | SCV003828082 | uncertain significance | not provided | 2020-03-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275018 | SCV001459757 | likely benign | Usher syndrome type 2A | 2020-04-30 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004543495 | SCV004792503 | likely benign | USH2A-related disorder | 2024-08-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |